\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ was\\ tachypnic\\ and\\ pale\\.\\ \\ her\\ oxygen\\ saturation\\ was\\ 93\\%\\ on\\ room\\ air\\.\\ \\ lab\\ work\\ showed\\ a\\ hematocrit\\ and\\ hemoglobin\\ of\\ 4\\.5\\ and\\ 15\\.7\\,\\ respectively\\.\\ \\ her\\ coagulation\\ studies\\ were\\ normal\\.\\ \\ blood\\ gas\\ showed\\ a\\ po2\\ of\\ 55\\.\ \(0\)\
\-\ patient\\ was\\ anticoagulated\\ with\\ heparin\\ and\\ coumadin\\ for\\ treatment\\ of\\ her\\ pulmonary\\ embolus\\.\ \(0\)\
\-\ a\\ ct\\ pe\\/dvt\\ protocol\\ was\\ initially\\ performed\\ following\\ transfusion\\ of\\ 3\\ units\\ of\\ blood\\.\\ \\ \\ the\\ study\\ was\\ limited\\ secondary\\ to\\ patient\\â\\€\\™s\\ respiratory\\ motion\\.\\ \\ a\\ questionable\\ filling\\ defect\\ was\\ thought\\ to\\ be\ \(0\)\
\-\ pulmonary\\ embolus\ \(16\)\
\-\ pulmonary\\ embolus\ \(16\)\
\-\ 84\\ year\\ old\\ woman\\ with\\ past\\ medical\\ history\\ significant\\ for\\ depression\\,\\ presented\\ to\\ the\\ pulmonology\\ clinic\\ with\\ 2\\-3\\ month\\ history\\ of\\ fatigue\\ which\\ had\\ increased\\ in\\ the\\ last\\ 2\\-3\\ weeks\\.\\ \\ patient\\ also\\ reported\\ increased\\ difficulty\\ breathing\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ embolus\\:\\ 0\\.3611262113831839\ \(0\)\
\-\ was\\:\\ 0\\.23530567376727765\ \(0\)\
\-\ her\\:\\ 0\\.21090596924845398\ \(0\)\
\-\ pulmonary\\:\\ 0\\.20577558321903297\ \(0\)\
\-\ tachypnic\\:\\ 0\\.1582868057971079\ \(0\)\
\-\ po2\\:\\ 0\\.15028823677339112\ \(0\)\
\-\ pulmonology\\:\\ 0\\.15028823677339112\ \(0\)\
\-\ showed\\:\\ 0\\.1499050828593459\ \(0\)\
\-\ patient\\:\\ 0\\.14640066745580219\ \(0\)\
\-\ anticoagulated\\:\\ 0\\.13774215093963463\ \(0\)\
\-\ transfusion\\:\\ 0\\.13265598227595243\ \(0\)\
\-\ of\\:\\ 0\\.13212904076022486\ \(0\)\
\-\ coagulation\\:\\ 0\\.13093951767571232\ \(0\)\
\-\ blood\\:\\ 0\\.13070556777514789\ \(0\)\
\-\ pale\\:\\ 0\\.1301342263341724\ \(0\)\
\-\ 93\\:\\ 0\\.1252644426387313\ \(0\)\
\-\ coumadin\\:\\ 0\\.1252644426387313\ \(0\)\
\-\ heparin\\:\\ 0\\.12294094865199556\ \(0\)\
\-\ increased\\:\\ 0\\.12170110445096245\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.11898233821525464\ \(0\)\
\-\ units\\:\\ 0\\.11898233821525464\ \(0\)\
\-\ depression\\:\\ 0\\.11726587361501453\ \(0\)\
\-\ saturation\\:\\ 0\\.11685911902969291\ \(0\)\
\-\ 84\\:\\ 0\\.11685911902969291\ \(0\)\
\-\ hematocrit\\:\\ 0\\.11646058227347462\ \(0\)\
\-\ respectively\\:\\ 0\\.11646058227347462\ \(0\)\
\-\ oxygen\\:\\ 0\\.11568687924689451\ \(0\)\
\-\ questionable\\:\\ 0\\.11458040803262631\ \(0\)\
\-\ breathing\\:\\ 0\\.11010687378416824\ \(0\)\
\-\ protocol\\:\\ 0\\.10982302862123487\ \(0\)\
\-\ fatigue\\:\\ 0\\.10899520512592918\ \(0\)\
\-\ lab\\:\\ 0\\.10163747337783498\ \(0\)\
\-\ gas\\:\\ 0\\.09854345786577227\ \(0\)\
\-\ thought\\:\\ 0\\.09716124217148396\ \(0\)\
\-\ clinic\\:\\ 0\\.09478836918906007\ \(0\)\
\-\ difficulty\\:\\ 0\\.09465729296942116\ \(0\)\
\-\ and\\:\\ 0\\.09301129672823692\ \(0\)\
\-\ room\\:\\ 0\\.09208856198591857\ \(0\)\
\-\ work\\:\\ 0\\.09174745437790875\ \(0\)\
\-\ last\\:\\ 0\\.09152328266469402\ \(0\)\
\-\ limited\\:\\ 0\\.08981610786847641\ \(0\)\
\-\ respiratory\\:\\ 0\\.08951183090829734\ \(0\)\
\-\ initially\\:\\ 0\\.08824497752217761\ \(0\)\
\-\ motion\\:\\ 0\\.08723311991123073\ \(0\)\
\-\ filling\\:\\ 0\\.08714365536570448\ \(0\)\
\-\ history\\:\\ 0\\.08598549546289763\ \(0\)\
\-\ to\\:\\ 0\\.08439639182757655\ \(0\)\
\-\ studies\\:\\ 0\\.08254631981833874\ \(0\)\
\-\ defect\\:\\ 0\\.08254631981833874\ \(0\)\
\-\ reported\\:\\ 0\\.08104907815105049\ \(0\)\
\-\ study\\:\\ 0\\.07504900567312671\ \(0\)\
\-\ air\\:\\ 0\\.073604360735602\ \(0\)\
\-\ past\\:\\ 0\\.0732481090948118\ \(0\)\
\-\ medical\\:\\ 0\\.07151693938880149\ \(0\)\
\-\ month\\:\\ 0\\.06845293867861138\ \(0\)\
\-\ for\\:\\ 0\\.06821359902846132\ \(0\)\
\-\ following\\:\\ 0\\.06750694723395487\ \(0\)\
\-\ weeks\\:\\ 0\\.0674410810676645\ \(0\)\
\-\ the\\:\\ 0\\.06736108224946556\ \(0\)\
\-\ secondary\\:\\ 0\\.06669901701896078\ \(0\)\
\-\ performed\\:\\ 0\\.06657276443776307\ \(0\)\
\-\ with\\:\\ 0\\.06610399391529724\ \(0\)\
\-\ presented\\:\\ 0\\.06562077606389871\ \(0\)\
\-\ significant\\:\\ 0\\.06497200045351735\ \(0\)\
\-\ woman\\:\\ 0\\.05860568288837276\ \(0\)\
\-\ were\\:\\ 0\\.05800565754898684\ \(0\)\
\-\ had\\:\\ 0\\.05606628776941431\ \(0\)\
\-\ treatment\\:\\ 0\\.053603727366358496\ \(0\)\
\-\ also\\:\\ 0\\.05293060785139173\ \(0\)\
\-\ which\\:\\ 0\\.05116824079739144\ \(0\)\
\-\ normal\\:\\ 0\\.04594500217548362\ \(0\)\
\-\ be\\:\\ 0\\.045648681578117335\ \(0\)\
\-\ ct\\:\\ 0\\.042841001610288906\ \(0\)\
\-\ year\\:\\ 0\\.03467934760037027\ \(0\)\
\-\ on\\:\\ 0\\.03398581233046601\ \(0\)\
\-\ old\\:\\ 0\\.03330417825043924\ \(0\)\
\-\ in\\:\\ 0\\.027993664320597387\ \(0\)\
